Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-12-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1120207/full |
_version_ | 1828090592964378624 |
---|---|
author | Roberta Zappasodi Graham P. Cook Alison Taylor |
author_facet | Roberta Zappasodi Graham P. Cook Alison Taylor |
author_sort | Roberta Zappasodi |
collection | DOAJ |
first_indexed | 2024-04-11T06:00:04Z |
format | Article |
id | doaj.art-a8ac33c904c64e34a07965b23a43f5f7 |
institution | Directory Open Access Journal |
issn | 1664-3224 |
language | English |
last_indexed | 2024-04-11T06:00:04Z |
publishDate | 2022-12-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Immunology |
spelling | doaj.art-a8ac33c904c64e34a07965b23a43f5f72022-12-22T04:41:47ZengFrontiers Media S.A.Frontiers in Immunology1664-32242022-12-011310.3389/fimmu.2022.11202071120207Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapyRoberta Zappasodi0Graham P. Cook1Alison Taylor2Weill Cornell Medicine, Cornell University and Memorial Sloan Kettering Cancer Center, New York City, NY, United StatesLeeds Institute of Medical Research, University of Leeds School of Medicine, Leeds, United KingdomLeeds Institute of Medical Research, University of Leeds School of Medicine, Leeds, United Kingdomhttps://www.frontiersin.org/articles/10.3389/fimmu.2022.1120207/fullimmunotherapytumour immunologyimmune checkpoint blockadecheckpoint inhibitorscancer |
spellingShingle | Roberta Zappasodi Graham P. Cook Alison Taylor Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy Frontiers in Immunology immunotherapy tumour immunology immune checkpoint blockade checkpoint inhibitors cancer |
title | Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy |
title_full | Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy |
title_fullStr | Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy |
title_full_unstemmed | Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy |
title_short | Editorial: Factors determining long term anti-tumor responses to immune checkpoint blockade therapy |
title_sort | editorial factors determining long term anti tumor responses to immune checkpoint blockade therapy |
topic | immunotherapy tumour immunology immune checkpoint blockade checkpoint inhibitors cancer |
url | https://www.frontiersin.org/articles/10.3389/fimmu.2022.1120207/full |
work_keys_str_mv | AT robertazappasodi editorialfactorsdetermininglongtermantitumorresponsestoimmunecheckpointblockadetherapy AT grahampcook editorialfactorsdetermininglongtermantitumorresponsestoimmunecheckpointblockadetherapy AT alisontaylor editorialfactorsdetermininglongtermantitumorresponsestoimmunecheckpointblockadetherapy |